TY - JOUR T1 - The <em>ABO</em> blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis JF - medRxiv DO - 10.1101/2020.05.31.20114991 SP - 2020.05.31.20114991 AU - David Ellinghaus AU - Frauke Degenhardt AU - Luis Bujanda AU - Maria Buti AU - Agustín Albillos AU - Pietro Invernizzi AU - Javier Fernández AU - Daniele Prati AU - Guido Baselli AU - Rosanna Asselta AU - Marit M Grimsrud AU - Chiara Milani AU - Fátima Aziz AU - Jan Kässens AU - Sandra May AU - Mareike Wendorff AU - Lars Wienbrandt AU - Florian Uellendahl-Werth AU - Tenghao Zheng AU - Xiaoli Yi AU - Raúl de Pablo AU - Adolfo Garrido Chercoles AU - Graduate in Chemistry AU - Adriana Palom AU - Alba-Estela Garcia-Fernandez AU - Francisco Rodriguez-Frias AU - Alberto Zanella AU - Alessandra Bandera AU - Alessandro Protti AU - Alessio Aghemo AU - Ana Lleo AU - Andrea Biondi AU - Andrea Caballero-Garralda AU - Andrea Gori AU - Anja Tanck AU - Anna Latiano AU - Anna Ludovica Fracanzani AU - Anna Peschuk AU - Antonio Julià AU - Antonio Pesenti AU - Antonio Voza AU - David Jiménez AU - Beatriz Mateos AU - Beatriz Nafria Jimenez AU - Graduate in Biotechnology AU - Carmen Quereda AU - Claudio Angelini AU - Cristina Cea AU - Aurora Solier AU - David Pestaña AU - Elena Sandoval AU - Elvezia Maria Paraboschi AU - Enrique Navas AU - Ferruccio Ceriotti AU - Filippo Martinelli-Boneschi AU - Flora Peyvandi AU - Francesco Blasi AU - Luis Téllez AU - Albert Blanco-Grau AU - Giacomo Grasselli AU - Giorgio Costantino AU - Giulia Cardamone AU - Giuseppe Foti AU - Serena Aneli AU - Hayato Kurihara AU - Hesham ElAbd AU - Ilaria My AU - Javier Martin AU - Jeanette Erdmann AU - José Ferrusquía-Acosta AU - Koldo Garcia-Etxebarria AU - Laura Izquierdo-Sanchez AU - Graduate in Biochemistry, MS AU - Laura Rachele Bettini AU - Leonardo Terranova AU - Leticia Moreira AU - Luigi Santoro AU - Luigia Scudeller AU - Francisco Mesonero AU - Luisa Roade AU - Marco Schaefer AU - Maria Carrabba AU - Maria del Mar Riveiro Barciela AU - Maria Eloina Figuera Basso AU - Maria Grazia Valsecchi AU - María Hernandez-Tejero AU - Marialbert Acosta-Herrera AU - Mariella D’Angiò AU - Marina Baldini AU - Marina Cazzaniga AU - Martin Schulzky AU - Maurizio Cecconi AU - Michael Wittig AU - Michele Ciccarelli AU - Miguel Rodríguez-Gandía AU - Monica Bocciolone AU - Monica Miozzo AU - Nicole Braun AU - Nilda Martínez AU - Orazio Palmieri AU - Paola Faverio AU - Paoletta Preatoni AU - Paolo Bonfanti AU - Paolo Omodei AU - Paolo Tentorio AU - Pedro Castro AU - Pedro M. Rodrigues AU - Aaron Blandino Ortiz AU - Ricardo Ferrer Roca AU - Roberta Gualtierotti AU - Rosa Nieto AU - Salvatore Badalamenti AU - Sara Marsal AU - Giuseppe Matullo AU - Serena Pelusi AU - Valter Monzani AU - Tanja Wesse AU - Tomas Pumarola AU - Valeria Rimoldi AU - Silvano Bosari AU - Wolfgang Albrecht AU - Wolfgang Peter AU - Manuel Romero Gómez AU - Mauro D’Amato AU - Stefano Duga AU - Jesus M. Banales AU - Johannes R Hov AU - Trine Folseraas AU - Luca Valenti AU - Andre Franke AU - Tom H Karlsen Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/02/2020.05.31.20114991.abstract N2 - Background Respiratory failure is a key feature of severe Covid-19 and a critical driver of mortality, but for reasons poorly defined affects less than 10% of SARS-CoV-2 infected patients.Methods We included 1,980 patients with Covid-19 respiratory failure at seven centers in the Italian and Spanish epicenters of the SARS-CoV-2 pandemic in Europe (Milan, Monza, Madrid, San Sebastian and Barcelona) for a genome-wide association analysis. After quality control and exclusion of population outliers, 835 patients and 1,255 population-derived controls from Italy, and 775 patients and 950 controls from Spain were included in the final analysis. In total we analyzed 8,582,968 single-nucleotide polymorphisms (SNPs) and conducted a meta-analysis of both case-control panels.Results We detected cross-replicating associations with rs11385942 at chromosome 3p21.31 and rs657152 at 9q34, which were genome-wide significant (P&lt;5×10−8) in the meta-analysis of both study panels, odds ratio [OR], 1.77; 95% confidence interval [CI], 1.48 to 2.11; P=1.14×10−10 and OR 1.32 (95% CI, 1.20 to 1.47; P=4.95×10−8), respectively. Among six genes at 3p21.31, SLC6A20 encodes a known interaction partner with angiotensin converting enzyme 2 (ACE2). The association signal at 9q34 was located at the ABO blood group locus and a blood-group-specific analysis showed higher risk for A-positive individuals (OR=1.45, 95% CI, 1.20 to 1.75, P=1.48×10−4) and a protective effect for blood group O (OR=0.65, 95% CI, 0.53 to 0.79, P=1.06×10−5).Conclusions We herein report the first robust genetic susceptibility loci for the development of respiratory failure in Covid-19. Identified variants may help guide targeted exploration of severe Covid-19 pathophysiology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe IKMB's core facilities received infrastructure support by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI, EXC2167). The project also received support through a philanthropic donation by Stein Erik Hagen and Canica AS.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The following ethical approvals of the project were obtained from the relevant ethics committees: Germany: Kiel (reference number D464/20); Italy: Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico (reference number 342_2020 and 334-2020 for cases and controls, respectively), Humanitas Clinical and Research Center, IRCCS (reference number 316/20), San Gerardo Hospital School of Medicine, Monza (the ethics committee of the National Institute of Infectious Diseases Lazzarro Spallanzani reference number 84/2020); Norway: Regional Committee for Medical and Health Research Ethics in South-Eastern Norway (reference number 132550); Spain: Hospital Clinic and IDIBAPS, Barcelona (reference number HCB/2020/0405), Hospital Universitario Vall d'Hebron, Barcelona (reference PR[AG]244/2020), Hospital Universitario Ramon y Cajal, Madrid (reference number 093/20), Donostia University Hospital, San Sebastian (reference number PI2020064).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary statistics will be made available upon request and after signing of appropriate institutional data transfer agreements, after acceptance of the peer-reviewed manuscript. ER -